Maker of promising Alzheimer's drug Leqembi expects full FDA approval this summer, expanded Medicare coverage

Even if the FDA grants full approval of the Alzheimer's treatment Leqembi, the rollout will take years.

from Health and Science https://ift.tt/syzIjxG
https://ift.tt/KwJtWyi
https://ift.tt/L1jaiGP